# Exploratory Study of Biotelemetry in Amyotrophic Lateral Sclerosis

> **NCT02447952** · NA · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 25 (actual)

## Conditions studied

- Amyotrophic Lateral Sclerosis

## Interventions

- **DEVICE:** Faros Sensor (FS) and LifeInsight Hub
- **DEVICE:** Fast Fix electrode patch
- **PROCEDURE:** Quantitative Measure of Speech (Core Phase Only)

## Key facts

- **NCT ID:** NCT02447952
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06-30
- **Primary completion:** 2017-06-01
- **Final completion:** 2017-06-01
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2018-12-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02447952

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02447952, "Exploratory Study of Biotelemetry in Amyotrophic Lateral Sclerosis". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02447952. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*